Research Funding Board

Ongoing

A-T Children’s Project – Research Grant Program

• Due: LOI submission rolling
• Funding: Up to $75,000 per year
• Project period: 1 to 2 years
• Purpose: To support translational and clinical research grants for research related to ataxia-telangiectasia including disease-modifying strategies that would prevent, slow, or stop the progression of the disease, symptom-improving strategies that address neural circuit function, immune system health and lung function, especially the neurological symptoms. (Grant decisions made and communicated 90 days after submission.)
• Eligibility: Investigators at all levels eligible to apply. Early career scientists are particularly encouraged to apply.

Alexander von Humboldt Research Foundation – Humboldt Research Fellowship

• Due: Rolling (selection committee meets: Feb/Mar, June/July, Oct/Nov)
• Funding: €3,170 monthly; €2,670 monthly (postdoctoral)
• Project period: 6 – 18 months; 6 – 24 months (postdoctoral)
• Purpose: To support research by scientists at any stage of their career in collaboration with a host at a German research institution of choice. Further financial support may be available. Allow 4 months for the review process.
• Eligibility: Eligible candidates must be postdoctorals (within 6 months of completing terminal degree to those who have completed their degree within the last 4 years), and established scientists who have completed their terminal degree within the last 12 years. November will be the final review cycle for 2022.

Allen Institute for AI – Allen AI Young Investigators

• Due: Rolling
• Funding: $100,000
• Project period:  1 to 3 years
• Purpose: To support postdocs in gaining research experience by providing opportunities to work collaboratively on AI2 projects while pursuing independent research agendas.
• Eligibility: Candidates should be withing 1 year of completing their PhD, or already have a PhD.

Alzheimer’s Association – Alzheimer’s Association Funding Program for Global Real-World Data Platforms (ALZ_RWD)

• Due: Rolling
• Funding: $100,000 to $1M
• Project period:  1 to 2 years
• Purpose: To support acceleration of global initiatives focused on developing, expanding and aligning RWD platforms’ infrastructure, data and impact with Alzheimer’s Network for Treatment and Diagnostics ALZ-NET (ALZ-NET), which seeks to connect clinical data from Alzheimer’s patients to the network of medical professional and researchers to encourage robust information sharing and education.
• Eligibility: A PI candidate must be a full-time faculty member or full-time paid employee of the organization submitting a proposal. See other eligibility requirements.

Alzheimer’s Association – Alzheimer’s Association World Wide FINGERS Network Funding Program (ALZ WW-FNFP)

• Due: Open
• Funding:Up to $1M
• Project period:  Up to 3 years
• Purpose: To provide startup funding and/or opportunities for ongoing studies to initiate WW-FINGERS (Worldwide Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) like studies, to expand these studies or to add unique opportunities that enhance the study through global collaboration of data sharing to facilitate rapid knowledge dissemination and implementation.
• Eligibility: Open to U.S. and international researchers with proposals that focus on program objectives.

Alzheimer’s Association – Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN)

• Due: Rolling
• Funding: Not specified
• Project period:  Up to 3 to 12 months
• Purpose: To support early career researchers who have not yet had the opportunity to fully establish their labs and acquire ongoing funding, and to provide bridge or interim funding for salary and other direct costs for research projects focused on Alzheimer’s disease, Frontotemporal Dementia, Parkinson’s disease, Dementia with Lewy Bodies, atypical Parkinson’s and/or other related disorders that have been impacted by NIH changes.
• Eligibility: An applicant must be an Early Stage Investigator (ESI), defined as a Program Director/Principal Investigator who has completed their terminal research degree or post-graduate clinical training, whichever is later, within the past 10 years and has not previously competed successfully as a PD/PI for a substantial NIH independent research award (see NIH early career definition for more details). This grant is intended for ESI applicants who can demonstrate disruption in either their K or R or other ESI specific investigator-led award in recent months due to U.S. federal funding challenges and must provide the NIH review and/or summary. Applicants must be able to demonstrate financial need for their continued research program to move forward.

Angelman Syndrome Foundation – Angelman Syndrome Research Proposals Call for Proposals

• Due: Rolling; submission deadlines for subsequent review ocurring on August 15
• Funding: Up to $100,000 per year
• Project period:  1 to 2 years
• Purpose: To support research projects that address areas of unmet need in Angelman Syndrome research. Priority areas to include studying or correcting the heterozygous effect on non-UBE3A genes in deletion. See other priority areas.
• Eligibility: Researchers at all levels are eligible.

Boehringer Ingelheim U.S. – Investigator-InitiatedStudies(IIS)

• Due: Open
• Funding: Not Specified
• Project period:  Not Specified
• Purpose: To support proof of concept or exploratory studies and interventional and non-interventional and health outcomes research studies proposals. Priority Areas (proposals outside of priority areas will also be evaluated): Cardio-Renal-metabolic, Mental Health, Dermatology.
• Eligibility: Intended for U.S. based researchers.

Brutten Family Foundation – Grants

• Due: Open
• Funding: Not Specified
• Project period:  Not Specified
• Purpose: To fund projects that address an urgent need and have a clear strategy and goal towards supporting the well being of communities.
• Eligibility: Proposals with a clear goal, strategy, and timeline that align with BFF’s main pillars (the environment, education, and mental health) may be submitted. 501(c)(3) status required.

Childhood Arthritis and Rheumatology Research Alliance – Data Analysis Grant

• Due: Rolling submission
• Funding: Up to $10,000
• Project period:  Not specified
• Purpose: To support qualitative or quantitative data analyses on existing CARRA datasets from collaborative research projects. Funds may be requested to complete a specific set of tasks that will result in the timely publication of results.
• Eligibility: Researcher should have necessary data in hand at time of application submission.

Cystic Fibrosis Foundation – Path to a Cure: Pioneer Award

• Due: LOI submission rolling
• Funding: Negotiable
• Project period:  Not specified
• Purpose: To support development of treatments for the underlying cause of the disease and, ultimately, a cure for CF.
• Eligibility: Matching funding required. U.S.-based and non U.S.-based research and development focused companies welcome to apply. Milestone completion and subsequent funding requirement.

Conservation, Food & Health Foundation – Conservation, Food & Health Foundation Grants

• Due: January 1 (Round 1); July 1 (Round 2) annually
• Funding: $25,000-$50,000
• Project period: 1 to 2 years
• Purpose: To support projects that have the potential to advance the field, build capacity in local areas, promote replication, influence public opinion and policy, affect systems change, and benefit people beyond the scope of the immediate project (projects focused on underfunded issues and geographic areas preferred).
• Eligibility: Non-governmental local, state, and regional organizations in Africa, Asia, the Caribbean, Latin America, and the Middle East in the countries where the projects are base and organizations from upper-income countries working with local partners in these areas.

Cystic Fibrosis Foundation – Student Loan Repayment Program

• Due: During and up to 4 months after active award period
• Funding: $14,000 per year maximum
• Project period: One-time payment
• Purpose: To assist with repayment of educational loan debt associated with a graduate-level degree.
• Eligibility: Applicants must be current awardees of one of the following CFF programs: 1. First through fifth Year Clinical Fellows, 2. Harry Shwachman CF Clinical Investigator, 3. LeRoy Matthews Physician-Scientist, 4. Envision CF: Emerging Leaders in CF Endocrinology II Program, and 5. Developing Innovative Gastroenterology Specialty Training (DIGEST) Program. Other eligibility requirements may apply.

Department of Defense (DOD) – Air Force Research Laboratory (AFRL) – Neuroscience

• Due: Rolling
• Funding: Stipend (amount not specified)
• Project period: 1 year
• Purpose: To support mentored training of postdoctoral scientists who will gain hands-on experience and develop skills in molecular neuroscience research. Project focus: comparing how secondary insults after traumatic brain injury worsen cognition and motor activity, and increase damage to lungs, gut, and kidney. Program administered by Oak Ridge Associated Universities (ORAU).
• Eligibility: PhD received within 5 years of award date and 2-4 years of neuroscience research using quantitative neuropathology and immunohistochemistry required.

Diamond Blackfan Anemia Foundation – Research Grant

• Due: Rolling
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that help investigators develop a clearer understanding of all aspects of Diamond Blackfan Anemia (DBA) pathophysiology.
• Eligibility: Postdoctoral fellows and researchers who have prior principal investigator (PI) experience may apply.

FamilieSCN2A Foundation – Hodgkin-Huxley Research Grant

• Due: Rolling (LOI)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that address fundamental gaps in the basic and translational science of SRDs and to accelerate therapy development to clinical trials in the SCN2A field.
• Eligibility: Established research scientists at accredited universities worldwide are eligible to apply.

Foundation for Anesthesia Education and Research (FAER) – Mentored Research Training Grants

• Due: February 15 and August 15 annually
• Funding: $250,000
• Project period: 2 years
• Purpose: To support the skills development of anesthesiologists and collection of preliminary data needed to be successful in obtaining future grants and publishing research as they seek to become independent investigators.
• Eligibility: Faculty members who have completed their core anesthesiology training within the past 10 years who are focused on any area of research that will contribute to advancement in patient care and has the potential to lead to extramural research (including basic science, clinical, translational, health services and education research.

Foundation for Anesthesia Education and Research (FAER) – Research Training Grants

• Due: February 15 and August 15 annually
• Funding: $75,000
• Project period: 1 year
• Purpose: To support training of anesthesiology residents in research techniques and scientific methods. Research areas: Basic science, clinical, translational, health services or education research.
• Eligibility: Anesthesiology trainees after CA-1 year; 80% protected time required.

Foundation for Anesthesia Education and Research (FAER) – Transition to Independence Grant

• Due: Rolling
• Funding: $75,000
• Project period: 1 year
• Purpose: To support the transition of scientists from mentored training-focused support to research independence for all types of cancers.
• Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission. 20% protected time required.

Foundation for Peripheral Neuropathy – Peripheral Neuropathy Research

• Due: Rolling LOI submission
• Funding: Not specified
• Project period: Not specified
• Purpose: To new investigators seeking to conduct research on regeneration and recovery related to peripheral nerves, encourage well-established researchers in other areas to utilize their knowledge and skills to peripheral neuropathy research, and to enable researchers with novel ideas to test and develop pilot data for seeking larger awards from NIH and other funding entities.
• Eligibility: New investigators, established investigators new to peripheral neuropathy research, and researchers with novel ideas relevant to the topic may apply.

Gateway for Cancer Research – GFCR Grant Program

• Due: Rolling
• Funding: $200,000 to $1.5 M
• Project period: 2 to 5 years
• Purpose: To fund early phase clinical trials at renowned institutions for all types of cancers.
• Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Gateway for Cancer Research – SIO Integrative Program

• Due: Rolling
• Funding: $200,000 to $1.5 M
• Project period: 2 to 5 years
• Purpose: To fund integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment and increase quality of life, especially post-treatment.
• Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Gateway for Cancer Research – NCI/SPORE Program

• Due: Rolling
• Funding: $200,000 to $800,000
• Project period: 2 to 5 years
• Purpose: A partnership with the NCI to give SPORE recipients a chance to apply for supplemental funding for their early phase, innovative clinical trials and enable principal investigators and their respective institutions to start a new trial through an additional arm, add patient cohorts and/or new correlative analysis.
• Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Hearst Foundations – Funding Priorities in Health

• Due: Rolling
• Funding: $100,000 minimum
• Project period: Not specified
• Purpose: To support healthcare programs focused on a number of different issues including improving access to high-quality healthcare for low-income populations and/or veterans, offering comprehensive healthcare to elderly populations, scaling innovative healthcare delivery systems to provide efficient, coordinated care, and research, particularly for early career investigators and/or efforts to find new cures for prevalent diseases like cancer.
• Eligibility: U.S.-based early career researchers may apply. Funding also supports U.S.-based regional hospitals, medical centers and specialized medical institutions providing access to healthcare for high-need populations. Professional development proposals will also be considered.

Immune Tolerance Network – Request for Applications

• Due: Open; Concept Proposals accepted year-round
  • Full applications accepted by invitation
• Funding: Not specified
• Project period: Not specified
• Purpose: To fund research in 1) allergy & asthma, 2) autoimmune diseases, 3) kidney & liver transplantation, and 4) assays & biomarkers.
• Note: ITN does not accept proposals for non-human or preclinical studies.

Lennox-Gastaut Syndrome (LGS) Foundation – Cure LGS 365 Research Grants

• Due: Open
• Funding: $25,000 (Level 1); $50,000 (level 2); $70,000 (level 3)
• Project period: Not specified
• Purpose: To provide seed funding for new basic, translational, and clinical research projects related to LGS, characterized by seizure types and hallmark EEG features. Priority areas include sleep, expressive communication, and EEG network evolution to LGS.
• Eligibility: Physicians and scientists holding a faculty or investigator appointment at any career level may apply.

Malan Syndrome Foundation – Research Grant Program

• Due: Rolling
• Funding: $30,000 per year
• Project period: 1 to 2 years
• Purpose: To support basic, translational, and clinical research that aims to advance the current understanding of Malan syndrome and identify disease-modifying treatments.
• Eligibility: Applicants must have a PhD, MD or equivalent and hold a full-time position as a researcher at any level (postdoctoral, staff scientist, assistant/associate/full professor) at an established academic or research institution, or pharmaceutical or biotechnology company. The proposed research must align with one of the high-priority research areas: 1) Creating novel disease models that replicate the human phenotype; increased understanding of the mechanisms regulating NFIX gene expression; 2) Identification of druggable targets that can increase NFIX expression and rescue haploinsufficient phenotype; 3) Identification of molecular pathophysiology associated with Malan syndrome in the central nervous system, and in cardiovascular, orthopedic, neuro-ophthalmologic, gastrointestinal and other pertinent areas that can inform translational research for drug discovery.

Michael J. Fox Foundation – Parkinson’s Disease Therapeutics Pipeline Program

• Due: Rolling pre-application
  • Full applications accepted by invitation
• Funding: Not specified
• Project period: Not specified
• Purpose: To advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease, to prevent, stop, or delay disease progression or reduce the burden of daily symptoms. Applicants with selected pre-proposals will be invited to submit an application.
• Eligibility: Open to industry and industry-academia collaborations.

NIH/FIC/NCI – International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed

• Due: Standard March dates.
• Funding: Up to $150,000 per year
• Project period: Up to 5 years
• Purpose: To provide protected time for conducting postdoctoral mentored global health research in low-  and middle-income countries to strengthen global health research.

NIH – Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars

• Due: Varies by awarding IC
• Funding: Up to $50,000 direct costs
• Project period: Up to 1 year
• Purpose: To sustain mentored investigator’s research during critical life events. Applications may be submitted in advance of a known event or after the fact.
• Note: Funds can be used for staff, supplies, or equipment within the original scope of research for the currently-funded grant period.

NIH – Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards

• Due: Varies by awarding IC
• Funding: Up to $50,000 direct costs
• Project period: Up to 1 year
• Purpose: To enhance the retention of investigators facing critical life events who are approaching the first renewal of their first independent grant or to a second new NIH grant.

NIH – Notice of Special Interest: NCI Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population

• Due: Rolling through May 7, 2029
• Funding: Not specified
• Project period: Up to 5 years
• Purpose: To support early career scientists conducting research within the mission of the Division of Cancer control and Population Sciences for the Mentored Research Scientist Development Award (K01), with the goal of eliminating cancer and its consequences for those impacted. Standard submission dates apply: Cycle 1- Feb 12; Cycle 2 – June 12; Cycle 3 – October 12.
• Eligibility: Candidates must have a research or health-professional doctoral degree and be a U.S. citizen, permanent resident, or a non-citizen national of the U.S. Mentor required. This opportunity may also support individuals who will be training in a new field or who have had a hiatus in their research career due to illness or pressing family circumstances.

National Institutes of Health – Career Development (K) Awards

• New Applications due: annually on June 12, October 12
• Renewal/Revision/Resubmission: annually on March 12, July 12, November 12

National Institutes of Health – Individual Fellowship (F) Awards

National Institutes of Health – NIH Small Grant Program (R03)

Pediatric Dermatology Research Alliance (PeDRA) – Study Support Grants

• Due: Rolling
• Funding: Up to $4,000
• Project Period: 6 months.
• Purpose: To fund statistical and/or publication support of active PeDRA Studies
• Eligibility: Study Support Grants are available to PeDRA Members only.  Please login or join PeDRA to access deadline details and other content.

Pediatric Brain Tumor Foundation – Pediatric Brain Tumor Research Funding Proposals

• Due: Rolling
• Funding: Not specified
• Project Period: 1 to 3 years
• Purpose: To provide seed funding for exploring novel concepts of rising stars in research as they pursue advancements and novel treatments for children with brain tumors and larger government-funded grants.
• Eligibility: Applicants must be early career scientists and/or clinicians studying any pediatric brain tumor type or subtype.

Rare Diseases Clinical Research Network – Congenital and Perinatal Infections Consortium Scholars Program

• Due: Rolling
• Funding: Not specified
• Project period: 2 years
• Purpose: Sponsored by the Career Enhancement Core of the Congenital and Perinatal Infections Consortium (CPIC) to support scholars conducting mentored research.
• Eligibility: Applicants must be fellows or early-stage faculty.

Rare Diseases Clinical Research Network – Pichichero Family Foundation Research Award in Pediatric Infectious Diseases Request for Proposals

• Due: Rolling
• Funding: $50,000
• Project period: Up to 2 years
• Purpose: To support outstanding investigators performing translational or clinical research focused on pediatric infectious diseases, with priority given to research involving vaccine development or that expands field knowledge of pathogenesis and moves the field towards the development of new vaccines and therapeutics.
• Eligibility: Applicants must be members of PIDS. Intended for Pediatric infectious diseases physicians and scientists with MDs and/or PhDs. Established investigators whose pursuing a new direction in research may also apply.

Rare Diseases Clinical Research Network – VCRC-VF Fellowship Program

• Due: Rolling
• Funding: Not specified.
• Project period: 2 years
• Purpose: Sponsored by the Vasculitis Clinical Research Consortium (VCRC) to provide mentored training for physician-investigators who show commitment to vasculitis and seek to pursue specialized training involving clinical and/or translational patient-oriented clinical investigation. Fellowships will begin in alignment with the academic calendar in North America (alternate schedules may be accepted).
• Eligibility: Applicants must have an MD, PhD, or equivalent and have completed residency and preferably have sub-specialty training relevant to vasculitis. A training license or full license to practice in the state/province where the fellowship will take place and host country citizenship or valid visa is required.

Robert Wood Johnson Foundation – Pioneering Ideas: Exploring the Future to Build a Culture of Health

• Due: Open
• Funding: Not specified
• Project period: Up to 3 years
• Purpose: To support research that addresses any four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work, and also research that offers novel approaches to advancing health equity and progress towards a Culture of Health.
• Eligibility: Lead applicants must be based in the U.S. if there are international collaborations. Preference will be given to applicants that are either public entities or nonprofit organization with tax-exempt status.

The Milbank Foundation – Grants

• Due: Open (LOIs required)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that seek to integrate people living with disabilities into all aspects of American life. Priorities include: rehabilitation and re-integration of veterans, especially veterans with disabilities, helping seniors to age where they choose through non-institutional, community-based health and social services, market-oriented, patient-centered health care reforms across the country, and mental health programs, substance abuse and suicide prevention, especially around young people.
• Eligibility: U.S.-based, tax-exempt organizations (under the U.S. IRS code) are eligible.

Tourette Association of America – Support for Research Consortia and Collaborative Research Projects

• Due: Rolling (LOI)
• Funding: Not specified
• Project period: Not specified
• Purpose: To provide seed funding to research consortia working on large issues relevant to TS, including the TAA genetics consortium, neuroimaging consortium, behavioral sciences consortium, deep brain stimulation registry and Treating Tourette Together summit and other projects that have direct impact on the patient and research community.
• Eligibility: Funding will be provided for projects involving collaboration among researchers and institutions.

W.K. Kellogg Foundation – Grants

• Due: Open (LOIs accepted at any time)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support organizations creating a world where children, families and communities can thrive. One area of focus: Increasing accessibility to health care for mothers, birthing people and babies where they live.
• Eligibility: Organizations with projects that match the mission (advancing innovative, community-driven solutions) of W.K. Kellogg Foundation may apply.

July

Pfizer – Implementing Shared Decision Making in Hemophilia Patient Care

• Due: July 21, 2026
• Funding: Up to $30,000
• Project Period: 18 months
• Purpose: To support Quality Improvement (QI) projects that integrate SDM tools, patient-reported outcomes (PROs) application and care algorithms into hemophilia patient care.
• Eligibility: The applicant must be the Project Lead/Principal Investigator (PI) or an authorized designee of such individual (e.g., Project Lead/PI’s grant/research coordinator) and be an employee or contractor of the requesting organization. For U.S.-based proposals medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations; government agencies; and other entities with a mission related to healthcare improvement.

American Association for Cancer Research – AACR-Debbie’s Dream Foundation Gastric Cancer Innovation and Discovery Grant

• Due: July 22, 2026
• Funding: $50,000
• Project Period: 1 year
• Purpose: A joint effort with Debbie’s Dream Foundation to support innovation and translation of ideas from basic research into new treatment options for gastric cancer, proposed by researchers currently in the field and investigators with experience in other areas of cancer or biomedical research.
• Eligibility: At the start of the grant term on November 1, 2026, applicants must have a PhD, MD, MD/PhD, or equivalent in a related field, be independent investigators, and work at an academic medical, or research institution. Applicants must be an active AACR member by the submission deadline for this grant.

American Board of Psychiatry and Neurology, Inc. – ABPN Dorthea Juul, PhD, Education Research Award

• Due: July 27, 2026
• Funding: Up to $100,000
• Project Period: Up to 2 years
• Purpose: To support research projects related to promoting lifelong learning and certifying psychiatrists and neurologists to high standards of expertise. Up to two psychiatry and two neurology awards will be made.
• Eligibility: Applicants must hold a full-time faculty appointment in a Psychiatry or Neurology department (or equivalent) at a U.S. LCME-accredited medical school, or, if the full-time faculty position is pending, submit with their application a chair letter that confirms their appointment start date before January 1, 2027. Physician applicants must be certified by the ABPN or the applicable ABMS member board, including active participation in continuing certification. Compliance with ABPN’s conflict of interest policies and procedures is required.

American Board of Psychiatry and Neurology, Inc. – ABPN Faculty Innovation in Education Award

• Due: July 27, 2026
• Funding: Up to $120,000
• Project Period: Up to 2 years
• Purpose: To support the development of innovative education and/or evaluation projects related to the mission by promoting lifelong learning and certifying psychiatrists and neurologists to high standards of expertise. Preference will be given to projects that have the potential for use in more than one site and to first-time applicants and applicants at a junior or mid-faculty level.
• Eligibility: Applicants must be certified by the ABPN, including active participation in continuing certification; hold a full-time faculty appointment in a Psychiatry or Neurology department (or equivalent) at a U.S. LCME-accredited medical school; or, if without a full-time faculty position, submit a department chair-validated offer letter with their application that confirms an appointment start date before January 1, 2027.  Applicants must also comply with the ABPN’s conflict of interest policies and procedures.

August

Damon Runyon Cancer Research Foundation – Damon Runyon Fellowship Award

• Due: August 14, 2026
• Funding: $70k to $76k (stipends that adjust annually), plus expenses
• Project Period: Over 4 years
• Purpose: To support theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention including molecular approaches to cancer prevention for inherited cancers.
• Eligibility: Applicants must have an MD, PhD, MD/PhD, DDS, DVM, DO, or equivalent. Basic and physician-scientists must have received their degrees no more than 18 months prior to the application deadline date. Applicants must not have been in their Sponsors’ labs for more than one year prior to the application deadline date. 100% protected time is required.

American Hearing Research Foundation (AHRF) – AHRF Discovery Grants

• Due: August 15, 2026
• Funding: Up to $50,000
• Project Period: 1 year
• Purpose: To support research focused on various aspects of hearing and balance disorders related to the inner ear, causes of Sudden Hearing Loss and Meniere’s Disease.
• Eligibility: Priority is given to investigators early in their careers who hold an MD, PhD, or equivalent degree, are affiliated with a university or hospital in the U.S., and need seed funding to generate preliminary data necessary for obtaining larger grants. 

American Hearing Research Foundation (AHRF) – AHRF Discretionary Grants

• Due: August 15, 2026
• Funding: $65,000-$75,000
• Project Period: 1 year
• Purpose: The $75,000 Birtman Grant, or the $65,000 Richard G. Muench Chairman’s Grant support exceptional scientific investigation focused on various aspects of hearing and balance disorders related to the inner ear.
• Eligibility: AHRF may identify one or two studies that show outstanding promise and may award a study with one of the two grants. If selected, the PI will be invited to submit a revised aims and budget for the additional funds.

Merck KGaA, Darmstadt, Germany – Research Grants

• Due: August 31, 2026
• Funding: Up to 100,000 to 500,000 EUR per year
• Project Period: Up to 1 to 3 years
• Purpose: To encourage innovation in key areas that will shape the future. Areas include: In-vitro models and assays to identify novel therapies for neuroinflammatory diseases; Artificial intelligence in cell culture media and process development; Innovative approaches to economical remediation of contaminated high volume materials; Condensate-based high-sensitivity cell-free screening assays for the modulation of protein-protein interactions; and Advancing molecule synthesis and discovery.
• Eligibility: Open to scientists in all career stages who are affiliated with any research-based institution, university or company.

November

Cystic Fibrosis Foundation – CFF/NIH R01-Unfunded Award

• Due: Rolling until November 30, 2026
• Funding: $125,000/year
• Project Period: 1 year
• Purpose: To support excellent cystic fibrosis-related research projects that have been approved by the National Institutes of Health (or governmental funding agencies in other countries) but cannot be supported by available funds.
• Eligibility: The application must have been reviewed by an NIH study section and presented to an institute council within 12 months of applying for the CF Foundation support and must have been submitted to NIH as an R01 and have an impact score of 45 or lower (1-45). If an application has been submitted to NIH multiple times, the most recent submission must have an impact score in this range. Unfunded resubmissions (A1 or other) may be submitted through this mechanism, but may be subject to additional scrutiny and must be distinct from any previously submitted NIH R01- Unfunded projects.

December

American Association of Immunologists – RESTORE Grant Program

• Due: Rolling through December 1, 2026
• Funding: Up to $100,000
• Project Period: 1 year
• Purpose: AAI member-led research projects funded by grants that were unexpectedly frozen or terminated by NIH or other federal government agencies for reasons other than scientific merit.
• Eligibility: Applicant must be the Principal Investigator (PI) or co-PI of an immunology-focused NIH R-, K-, or F-series grant (including K99/R00 and F99/K00 grants), a DP2 or DP5 grant, or a grant from NSF or another U.S. federal agency, that was awarded to an eligible institution (review criteria for more details) AND was terminated in 2025 or 2026 due to non-scientific reasons. International PIs with terminated U.S. federal grants by these mechanisms will be considered if their institution qualifies. New PIs whose start-up funding through the NIH FIRST Program was awarded to an eligible institution and was terminated in 2025 or 2026 are also eligible. Please review full eligibility criteria. Two to three years of membership required (2024-2026 with 2026 dues paid in full).

Damon Runyon Cancer Research Foundation – Damon Runyon Quantitative Biology

• Due: December 1, 2026
• Funding: $76k to $80k stipend
• Project Period: 3 years
• Purpose: To encourage scientists, trained in fields such as mathematics, computer science, physics, engineering, and/or a related field, to pursue research careers in computational biology under the joint mentorship of leaders in both computational science (“dry lab”) and cancer biology (“wet lab”).
• Eligibility: Applicants must have received a PhD, MD, MD/PhD, DDS, DVM, DO, or equivalent. Open to computational scientists with an interest in the intersection between quantitative biology, data science and cancer research. Basic and physician-scientists must have received their degrees no more than five years prior to the application deadline date and may apply at any time prior to their initial assistant professorship appointment (or equivalent). Applicants must not have been in their Mentors’ labs for more than 2 years prior to the application deadline date. 100% protected time required.

Awards